This dataset describes olfactory perception of androstenone (5α-androst-16-en-3-one) in residents of central Russia (n=807, 9-84 years old). Based on previous studies, 3.13 × 10−3% androstenone was utilized for sensory testing. A modified two-alternative choice task with “no-difference” options was applied as an odor discrimination procedure. The participants rated the perceived odor intensity and pleasantness on 3-point categorical scales. The subsequent task was free odor identification. We used a survey to determine characteristics of our study population such as age, sex, ethnicity, olfactory abilities, smoking habits, respiratory tract diseases, perfume use, blood group. To examine sex differences in characteristics of participants, as well as in their perception of androstenone, we have applied one-way ANOVA for age variable and Chi-square tests for categorical variables. The dataset will be useful for assessing the impact of the aforementioned factors on the perception of volatile steroids. A wide range of researchers studying verbal descriptors of specific odors and cross-cultural differences in olfactory perception may reuse this dataset. Primarily, this dataset may benefit meat industry, as androstenone, which is perceived as an unpleasant odor by about a quarter of the population, significantly contributes to pork flavor.
We have tested the original version of the University of Pennsylvania Smell Identification Test (UPSIT) on a population of Central Russia including groups of different ages residing in the city area...
The effects of the presentation rate of the domestic cat chemical L-felinine (0.05%) on the regulation of the estrous cycle in the house mouse were studied. It has been found that L-felinine has an...
Hormone changes across women’s menstrual cycles may lead to changes in their perceptions of chemical signals and their hormonal responses to these cues. The aim of the present study was to determine the role of menstrual cycle phase in the response to extracts of male axillary secretions (EMAS) in women. We tested healthy reproductive age and premenopausal women (n = 29). An EMAS/control solution was applied once every two hours during either the follicular or luteal phase, at which point saliva samples for luteinizing hormone (LH) and cortisol monitoring were collected. LH and cortisol concentrations were analyzed using the enzyme immunoassay (EIA) technique. Positive and Negative Affect Schedule (PANAS) and Visual Analogue Scales (VAS) scores were used to assess the participants’ moods. For the first time, we showed that EMAS may produce opposite effects on LH secretion depending on the menstrual cycle phase of the recipient. We observed a significant increase in the number of LH peaks (p = 0.0447) and their amplitudes (p = 0.0469) when EMAS was applied during the follicular phase, while the same application in the luteal phase lowered the amplitudes of LH peaks (p = 0.0382). For the first time, we showed that EMAS application increased salivary cortisol levels in reproductive age women relative to premenopausal women (p = 0.0032). PANAS scores revealed changes in positive and negative affect after EMAS application. Our data indicate the significance of the menstrual cycle phase for EMAS’ effects on LH secretion and mood, but not on cortisol secretion in women.
Hormone changes across women's menstrual cycle may lead to changes in perception of chemical signals and hormonal responses to these cues. The aim of the present study was to determine the role of menstrual cycle phase on the effects of extracts of male axillary secretions (EMAS) in women. We tested healthy reproductive age and premenopausal women (n=29). EMAS/control solution was applied once in two hours either in the follicular or luteal phase, while collecting saliva samples for LH and cortisol monitoring. LH and cortisol concentrations were analyzed using EIA technique. PANAS and VAS were used to assess the mood. We observed a significant increase in the number of LH peaks (p=0.0447) and their amplitude (p=0.0469) when EMAS was applied in the follicular phase. The same application in the luteal phase lowered the amplitude of LH peaks (p=0.0382). EMAS application increases salivary cortisol level in reproductive age women relative to premenopausal women (p=0.0032). PANAS revealed changes in positive and negative affect after EMAS application. Our data indicate the significance of the menstrual cycle phase for EMAS effects on LH secretion, mood, but not on cortisol secretion in women.
Sex differences in stress response continue to be understudied in basic physiological and behavioral research. The current study aimed to investigate the sex-specific effects of chronic stress in wild-derived house mice subjected to chronic unpredictable stress (CUS). The use of wild-derived mice enhanced the ecological validity of our stress model. We applied CUS for 5 weeks based on protocols previously established in laboratory mice, with regular weighting and welfare checks. Control mice were not subjected to stress. After the 5-week exposure, behavioral tests were performed, blood and hair samples were collected for corticosterone measurement, and stress-sensitive organ weights were assessed. Stressed females, but not stressed males, gained significantly less body weight over the entire CUS period. After CUS, mice tended to have higher adrenal and thymus weights. In stressed females, we observed significantly prolonged grooming time in the open field test and fewer immobility episodes in the tail suspension test (TST). Stressed males displayed significantly shorter immobility time in TST. Stressed males, but not stressed females, had significantly higher levels of hair corticosterone, with a similar tendency in plasma. Our results indicate different CUS coping strategies in males and females and raise a question about the development of different protocols for the assessment of stress responses in males and females.